Topical IL-10 enema treatment of patients with ulcerative colitis unveiled that IL-10 is effective in down-regulating pro-inflammatory cytokine synthesis from IBD monocytes and lymphocytes both in vitro and in vivo [27]. Here, IL10 is linked to inflammatory bowel disease.